Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 USD | +50.15% | +42.86% | -92.86% |
04-11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Business Summary
Number of employees: 12
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Drug Development and Commercialization
100.0
%
| 2 | 100.0 % | 5 | 100.0 % | +115.34% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 5 | 100.0 % | +115.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 24/05/23 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 15/10/23 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
John Dorbin
LAW | General Counsel | 53 | 18/10/23 |
Thomas H. Moll
PRN | Corporate Officer/Principal | 58 | 21/04/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 25/08/19 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 24/05/23 |
Vickie Reed
BRD | Director/Board Member | 62 | 23/05/22 |
Jannine Versi
BRD | Director/Board Member | 38 | 24/05/23 |
Meera Desai
BRD | Director/Board Member | 45 | 30/09/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,109,520 | 9,167,003 ( 90.68 %) | 7,470 ( 0.0739 %) | 90.68 % |
Company contact information
DMK Pharmaceuticals Corp.
11682 El Camino Real Suite 300
92130, San Diego
+858 997 2400
http://www.adamispharmaceuticals.comSector
1st Jan change | Capi. | |
---|---|---|
-92.86% | 505K | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- DMKPQ Stock
- Company DMK Pharmaceuticals Corporation